Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom ...

AIIMS researchers claim to have made significant progress in developing chimeric antigen receptor (CAR) T-cell therapy, ...

AIIMS Delhi has achieved a groundbreaking milestone in cancer treatment by developing an antibody-based therapy for recurrent cancers, specifically M ...

Despite being positive about DNA-based vaccine production in general, the study did identify areas in need of better ...

Gilead Sciences, Inc. has announced that Trodelvy (sacituzumab govitecan-hziy) has received Breakthrough Therapy Designation ...

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.

This revolutionary vaccine, set to be launched in early 2025, will be distributed free of cost to Russian citizens ...

anti-IL-7 Receptor Lusvertikimab in Ulcerative Colitis accepted for Oral Presentation and selected amongst the Top 10 oral ...

Africa's low COVID-19 mortality rates concealed important vulnerabilities, including poor health infrastructure and manufacturing constraints,1 highlighting the need for a proactive, continent-wide ...

Russia said it has developed a cancer vaccine that will be distributed to Russian patients for free starting in early 2025 — ...

Russia announced that it had developed an mRNA vaccine for cancer patients. The vaccine will be available from early 2025 and ...

SK Biopharmaceuticals will leverage ProEn Therapeutics’ ArtBody platform, a dual-target binding technology that incorporates small proteins1 to identify and target specific tumour antigens ... focuses ...